Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001531101-11-000001
Filing Date
2011-09-28
Accepted
2011-09-28 10:38:00
Documents
1
Period of Report
2010-09-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3325
  Complete submission text file 0001531101-11-000001.txt   4841
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2815 EASTLAKE AVENUE EAST, SUITE 300 SEATTLE WA 98102
Business Address
DePippo Lynn (Reporting) CIK: 0001531101 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27239 | Film No.: 111110950